Search results for "DAC"

showing 10 items of 1529 documents

Migraine and cluster headache – the common link

2018

Abstract Although clinically distinguishable, migraine and cluster headache share prominent features such as unilateral pain, common pharmacological triggers such glyceryl trinitrate, histamine, calcitonin gene-related peptide (CGRP) and response to triptans and neuromodulation. Recent data also suggest efficacy of anti CGRP monoclonal antibodies in both migraine and cluster headache. While exact mechanisms behind both disorders remain to be fully understood, the trigeminovascular system represents one possible common pathophysiological pathway and network of both disorders. Here, we review past and current literature shedding light on similarities and differences in phenotype, heritability…

medicine.medical_specialtyNeurologyCluster headacheImplantable Neurostimulators/statistics & numerical dataPain medicineCalcitonin Gene-Related PeptideDeep Brain StimulationMigraine DisordersNitroglycerin/adverse effectsHypothalamuslcsh:MedicineTriptansReviewCalcitonin gene-related peptideBioinformatics03 medical and health sciencesNitroglycerin0302 clinical medicinemedicineHumans030212 general & internal medicineTryptamines/pharmacologyMigraineTrigeminovascular systembusiness.industryNeuromodulationCluster Headache/bloodCluster headacheAnti-CGRP (receptor) monoclonal antibodies – mAbsMigraine Disorders/bloodTrigeminovascular systemlcsh:RGeneral MedicineCalcitonin gene-related peptide (CGRP)medicine.diseaseDeep Brain Stimulation/statistics & numerical dataNeuromodulation (medicine)Tryptamines3. Good healthCalcitonin Gene-Related Peptide/antagonists & inhibitorsAnesthesiology and Pain MedicineImplantable NeurostimulatorsMigraineNeurology (clinical)business030217 neurology & neurosurgerymedicine.drugThe Journal of Headache and Pain
researchProduct

Pediatric haedaches epidemiology in emergency department during COVID-19

2021

Background and aims Recent studies have showed that in emergency department (ED) pediatric admissions for headache are increasing in the last years. However Covid-19 pandemic may have changed the use of health services for several reasons. Aim of this study is to analyze the rates of admission for pediatric headaches in ED before and during Covid19 Pandemic. Methods we have collected retrospectively the records of children (range of age 5–14) admitted on ED in 2012, 2019 and 2020. We selected the records including Headache and Headache associated to other symptoms (vomit, fever, dizziness, etc.), collecting further the use of computed tomography (CT) and neurological consultation. Results I…

medicine.medical_specialtyNeurologyCoronavirus disease 2019 (COVID-19)business.industryEpidemiologymedicineNeurology (clinical)Emergency departmentMedical emergencybusinessmedicine.diseaseheadache pediatric headachesArticle
researchProduct

A PRISMA-compliant systematic review of the endpoints employed to evaluate symptomatic treatments for primary headaches

2018

Abstract Background Primary headache are prevalent and debilitating disorders. Acute pain cessation is one of the key points in their treatment. Many drugs have been studied but the design of the trials is not usually homogeneous. Efficacy of the trial is determined depending on the selected primary endpoint and usually other different outcomes are measured. We aim to critically appraise which were the employed outcomes through a systematic review. Methods We conducted a systematic review of literature focusing on studies on primary headache evaluating acute relief of pain, following the PRISMA guideline. The study population included patients participating in a controlled study about sympt…

medicine.medical_specialtyNeurologyHeadache Disorders Primaryendpointspractice guidelines as topiclcsh:MedicineTriptansPlacebopatient complianceanti-inflammatory agentsnon-steroidal03 medical and health sciences0302 clinical medicineQuality of lifeInternal medicineprimarymedicineClinical endpoint030212 general & internal medicinehumansdisabled personsclinical trialsnon-steroidal anti-inflammatorybusiness.industryAnti-Inflammatory Agents Non-Steroidallcsh:RtryptaminesCorrectionacuteGeneral MedicineGuidelineacute; clinical trials; endpoints; non-steroidal anti-inflammatory; primary headaches; prisma-guidelines; triptans; anti-inflammatory agents non-steroidal; chronic disease; disabled persons; headache disorders primary; humans; patient compliance; practice guidelines as topic; treatment outcome; tryptamines; quality of lifemedicine.diseasetriptansClinical trialAnesthesiology and Pain Medicineheadache disordersMigrainequality of lifetreatment outcomeprimary headachesNeurology (clinical)prisma-guidelinesbusinesschronic disease030217 neurology & neurosurgeryResearch Articlemedicine.drug
researchProduct

EHMTI-0220. Cortical excitability in episodic cluster headache.

2014

Methods Twenty-five patients with episodic CH and thirteen healthy subjects underwent an experimental session where we evaluated, in both hemispheres, motor-cortical response to: 1) single-pulse TMS: i.e. motor threshold (MT); input-output (IO) curves and cortical silent period (CSP) and 2) paired-pulse TMS: i.e. intracortical facilitation (ICF) and short intracortical inhibition (SICI). Thirteen patients were evaluated outside bout, while the remaining twelve patients were inside bout at the time of recording.

medicine.medical_specialtyNeurologybusiness.industrymusculoskeletal neural and ocular physiologyCluster headachemedicine.medical_treatmentHealthy subjectsGeneral MedicineAudiologymedicine.diseaseTranscranial magnetic stimulationAnesthesiology and Pain MedicineIntracortical facilitationEpisodic cluster headacheMeeting AbstractmedicineIntracortical inhibitionSilent periodNeurology (clinical)businesshuman activitiesNeuroscience
researchProduct

Continuity of healthcare for headacahe patients: a problem of communication between headache specialists and general pratictioners

2005

The continuous care of headache patients, from headache centres to general practice, is a managerial problem that is still unsolved in Italy. In fact, if on the one hand patients do not usually go to headache centres because of poor information, on the other hand, if they do, they do not find their general practitioner (GP) sufficiently prepared to continue the management. In Sicily we have formed a dense network of headache centres that we will try to link on the Internet to deal with the problem of poor patients information and poor specialist consultation. We also have faced the problem of the continuous care, trying to overcome "the difficulties of communication between specialists, GPs…

medicine.medical_specialtyPain medicineClinical NeurologyMEDLINESpecialistContinuous healthcareGeneral practitionerHealth careMedicineHumansReferral and ConsultationSicilyMigraineId migraineHeadache diagnosisInternetbusiness.industryMigraine Specialist General practitioner ID–Migraine Headache portal Continuous healthcareCommunicationHeadacheGeneral MedicineContinuity of Patient Caremedicine.diseaseAnesthesiology and Pain MedicineMigraineNeurologyFamily medicineGeneral practiceHeadache and Continuity in Health CareID–MigraineThe InternetSettore MED/26 - NeurologiaNeurology (clinical)businessFamily PracticeHeadache portal
researchProduct

The Global Campaign (GC) to Reduce the Burden of Headache Worldwide. The International Team for Specialist Education (ITSE)

2005

The social perception of headache, everywhere at low levels in industrialised countries, becomes totally absent in developing ones. Headache disorders came into the World Health Organization’s strategic priorities after publication of the 2001 World Health Report. Among the leading causes of disability, migraine was ranked 19th for adults of both sexes together and 12th for females. The Global Campaign (GC) to Reduce the Burden of Headache Worldwide was planned by the major international headache organizations together with WHO in order to identify and remove those cultural, social and educational barriers recognised as responsible factors for the inadequate treatment of headache disorders …

medicine.medical_specialtyPain medicineeducationClinical SciencesGlobal Campaign Against HeadacheClinical NeurologyAlternative medicineMEDLINEWorld Health OrganizationGlobal Healthmasterin headache medicineWorld healthEducationMigrainesClinical ResearchMedicalacademic formation; global campaign against headache; headache specialist education; masterin headache medicineHealth careGeneticsGlobal healthHumansMedicineHeadache specialist educationDental/Oral and Craniofacial DiseaseGraduateNeurology & NeurosurgeryHeadachesbusiness.industrySocial perceptionPain ResearchHeadacheNeurosciencesMaster in Headache MedicineGeneral Medicinemedicine.diseaseHeadaches Physicians and PatientsAcademic formationQuality EducationAnesthesiology and Pain MedicineNeurologyMigraineEducation Medical GraduateFamily medicineNeurology (clinical)Chronic PainbusinessThe Journal of Headache and Pain
researchProduct

Retinoblastoma and mosaic 13q deletion: a case report

2021

Abstract Background Patients with 13q-syndrome are at risk of retinoblastoma when the RB1 gene, located in the chromosomal band 13q14.2, is deleted. This syndrome is frequently associated with congenital malformations and developmental delay, although these signs could be mild. Mosaic 13q-deletion patients have been previously reported in the literature; their phenotype is variable, and they may not be recognized. Case presentation Retinoblastoma diagnosed in a child with 13q-mosaicism confirmed in blood, oral mucosa, healthy retina and retinoblastoma. A second RB1 hit is present exclusively in the retinoblastoma sample (RB1 c.958C>T p.Arg320Ter). Other detected molecular events in retin…

medicine.medical_specialtyPathology13q-syndromeClinodactylyCitogenèticaCase ReportPhysical examinationMalignancyGenètica molecularCytogeneticsMolecular geneticsMedicineMolecular geneticsCàncermedicine.diagnostic_test13q deletion syndromeMosaicismbusiness.industryRetinoblastomaRetinoblastomaCytogeneticsRE1-994medicine.diseasePhenotypeeye diseasesOphthalmologymedicine.symptombusiness
researchProduct

Indacaterol Provides Effective Bronchodilation In Patients With Chronic Obstructive Pulmonary Disease Irrespective Of Patient Age (<65 Or e65 Year…

2010

medicine.medical_specialtyPatient agebusiness.industryInternal medicineBronchodilationmedicineCardiologyIndacaterolPulmonary diseaseIn patientbusinessmedicine.drugC41. EMERGING PHARMACOLOGY FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE: MECHANISMS AND OUTCOMES
researchProduct

Osmophobia in migraine classification: a multicentre study in juvenile patients.

2010

Aims: This study was planned to investigate the diagnostic utility of osmophobia as criterion for migraine without aura (MO) as proposed in the Appendix (A1.1) of the International Classification of Headache Disorders (ICHD-II, 2004). Methods: We analysed 1020 patients presenting at 10 Italian juvenile headache centres, 622 affected by migraine (M) and 328 by tension-type headache (TTH); 70 were affected by headache not elsewhere classified (NEC) in ICHD-II. By using a semi-structured questionnaire, the prevalence of osmophobia was 26.9%, significantly higher in M than TTH patients (34.6% vs 14.3%). Results: Osmophobia was correlated with: (i) family history of M and osmophobia; and (ii) o…

medicine.medical_specialtyPediatricsAdolescentAuraMigraine Disordersosmophobia juvenile primary headache migraine without aura tension-type headache International Classification of Headache Disorder 2nd ednInternational Classification of Headache Disorder 2nd edn; Juvenile primary headache; Migraine without aura; Osmophobia; Tension-type headache;International Classification of Headache Disorder 2nd ednlaw.inventionRandomized controlled triallawInternational Classification of DiseasesSurveys and QuestionnairesmedicinePrevalenceJuvenileHumansFamily historyChildosmophobiabusiness.industryOsmophobiaKeywordsGeneral Medicinemedicine.diseasetension-type headachejuvenile primary headacheMulticenter studyMigrainemigraine without auraChild PreschoolOdorantsSensation DisordersPhysical therapyInternational Classification of Headache DisordersNeurology (clinical)businessCephalalgia : an international journal of headache
researchProduct

El conjunto mínimo básico de datos al alta hospitalaria como fuente de información para el estudio de las anomalías congénitas

1999

PURPOSE: The purpose of this study is that of assessing the validity of the computerized diagnoses of hospital discharges of congenital defects by comparing them with the information included in the medical history. MEANS AND METHODS: Based on the discharge records generated over a one-year period at 7 hospitals in the Autonomous Region of Valencia, 100 children were selected at random from each hospital. As a standard, the diagnoses stated in the medical histories were indexed and coded. Solely those discharges having taken place during the first year of life were considered. A study was also made of the type, seriousness and individual or combinations of congenital defects. A calculation …

medicine.medical_specialtyPediatricsValidaciónbusiness.industryMedical recordlcsh:Public aspects of medicinelcsh:Rlcsh:Medicinelcsh:RA1-1270General MedicineConjunto mínimo básico de datosRegistros de alta hospitalariaConfidence intervalEspecificidadDiagnósticos de alta hospitalaria/SensibilidadPositive predicative valuePredictive value of testsEpidemiologymedicineHospital dischargeAnomalías congénitasMedical historyMedical diagnosisbusinessRevista Española de Salud Pública
researchProduct